Dyadic International Secures Grant for Antibody Development

TipRanksNov 27 03:29

Express News | Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for Rsv and Malaria Using C1 Platform Technology

BreakingsNov 21 21:30

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

DyadicNov 21 13:00

Dyadic International, Inc. (DYAI) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 17 10:07 · Conference Call

HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target

BenzingaNov 14 18:56 · Ratings

Dyadic International Reports Q3 2024 Growth and Strategic Advances

TipRanksNov 13 12:15